Department of Anesthesia, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
Department of Anesthesia, Southwest Hospital, Army Medical University (The Third Military Medical University), Chongqing, China.
J Cell Physiol. 2021 Nov;236(11):7682-7697. doi: 10.1002/jcp.30420. Epub 2021 May 27.
Hepatopulmonary syndrome (HPS) markedly increases the mortality of patients. However, its pathogenesis remains incompletely understood. Rat HPS develops in common bile duct ligation (CBDL)-induced, but not thioacetamide (TAA)-induced cirrhosis. We investigated the mechanisms of HPS by comparing these two models. Pulmonary histology, blood gas exchange, and the related signals regulating macrophage accumulation were assessed in CBDL and TAA rats. Anti-polymorphonuclear leukocyte (antiPMN) and anti-granulocyte-macrophage colony stimulating factor (antiGM-CSF) antibodies, clodronate liposomes (CL), and monocyte chemoattractant protein 1 (MCP1) inhibitor (bindarit) were administrated in CBDL rats, GM-CSF, and MCP1 were administrated in bone marrow-derived macrophages (BMDMs). Pulmonary inflammatory cell recruitment, vascular dilatation, and hypoxemia were progressively developed by 1 week after CBDL, but only occurred at 4 week after TAA. Neutrophils were the primary inflammatory cells within 3 weeks after CBDL and at 4 week after TAA. M2 macrophages were the primary inflammatory cells, meantime, pulmonary fibrosis, GM-CSFR, and CCR2 were specifically increased from 4 week after CBDL. AntiPMN antibody treatment decreased neutrophil and macrophage accumulation, CL or the combination of antiGM-CSF antibody and bindarit treatment decreased macrophage recruitment, resulting in pulmonary fibrosis, vascular dilatation, and hypoxemia in CBDL rats alleviated. The combination treatment of GM-CSF and MCP1 promoted cell migration, M2 macrophage differentiation, and transforming growth factor-β1 (TGF-β1) production in BMDMs. Conclusively, our results highlight neutrophil recruitment mediates pulmonary vascular dilatation and hypoxemia in the early stage of rat HPS. Further, M2 macrophage accumulation induced by GM-CSF/GM-CSFR and MCP1/CCR2 leads to pulmonary fibrosis and promotes vascular dilatation and hypoxemia, as a result, HPS develops.
肝肺综合征(HPS)显著增加了患者的死亡率。然而,其发病机制仍不完全清楚。大鼠 HPS 发生于胆总管结扎(CBDL)诱导的肝硬化,而不是硫代乙酰胺(TAA)诱导的肝硬化。我们通过比较这两种模型来研究 HPS 的发病机制。在 CBDL 和 TAA 大鼠中评估了肺组织学、血气交换以及调节巨噬细胞积聚的相关信号。在 CBDL 大鼠中给予抗多形核白细胞(antiPMN)和抗粒细胞-巨噬细胞集落刺激因子(antiGM-CSF)抗体、氯膦酸二钠脂质体(CL)和单核细胞趋化蛋白 1(MCP1)抑制剂(bindarit),在骨髓源性巨噬细胞(BMDMs)中给予 GM-CSF 和 MCP1。CBDL 后 1 周,肺内炎症细胞募集、血管扩张和低氧血症逐渐发展,但仅在 TAA 后 4 周发生。中性粒细胞是 CBDL 后 3 周内和 TAA 后 4 周内的主要炎症细胞。M2 巨噬细胞是主要的炎症细胞,同时,从 CBDL 后 4 周开始,肺纤维化、GM-CSFR 和 CCR2 特异性增加。抗 PMN 抗体治疗可减少中性粒细胞和巨噬细胞的募集,CL 或抗 GM-CSF 抗体和 bindarit 的联合治疗可减少巨噬细胞的募集,从而减轻 CBDL 大鼠的肺纤维化、血管扩张和低氧血症。GM-CSF 和 MCP1 的联合治疗促进了 BMDMs 中的细胞迁移、M2 巨噬细胞分化和转化生长因子-β1(TGF-β1)的产生。综上所述,我们的研究结果强调了中性粒细胞募集介导了大鼠 HPS 早期的肺血管扩张和低氧血症。此外,GM-CSF/GM-CSFR 和 MCP1/CCR2 诱导的 M2 巨噬细胞积聚导致肺纤维化,并促进血管扩张和低氧血症,因此 HPS 发展。